BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 23340381)

  • 1. Cellular aspects of prion replication in vitro.
    Grassmann A; Wolf H; Hofmann J; Graham J; Vorberg I
    Viruses; 2013 Jan; 5(1):374-405. PubMed ID: 23340381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propagation and Dissemination Strategies of Transmissible Spongiform Encephalopathy Agents in Mammalian Cells.
    Heumüller SE; Hornberger AC; Hebestreit AS; Hossinger A; Vorberg IM
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission and Replication of Prions.
    Marín-Moreno A; Fernández-Borges N; Espinosa JC; Andréoletti O; Torres JM
    Prog Mol Biol Transl Sci; 2017; 150():181-201. PubMed ID: 28838661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
    Saá P; Cervenakova L
    Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.
    Priola SA; Vorberg I
    Mol Biotechnol; 2006 May; 33(1):71-88. PubMed ID: 16691009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prions and their partners in crime.
    Caughey B; Baron GS
    Nature; 2006 Oct; 443(7113):803-10. PubMed ID: 17051207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathology of Animal Prion Diseases.
    Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion diseases and their biochemical mechanisms.
    Cobb NJ; Surewicz WK
    Biochemistry; 2009 Mar; 48(12):2574-85. PubMed ID: 19239250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease and mad cows: lessons learnt from yeast cells.
    Hofmann J; Wolf H; Grassmann A; Arndt V; Graham J; Vorberg I
    Swiss Med Wkly; 2012; 142():w13505. PubMed ID: 22270552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prion strain phenomenon: molecular basis and unprecedented features.
    Morales R; Abid K; Soto C
    Biochim Biophys Acta; 2007 Jun; 1772(6):681-91. PubMed ID: 17254754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of prion-induced neurodegeneration.
    Saá P; Harris DA; Cervenakova L
    Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein misfolding and disease.
    Moore RA; Taubner LM; Priola SA
    Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.
    Caughey B; Baron GS; Chesebro B; Jeffrey M
    Annu Rev Biochem; 2009; 78():177-204. PubMed ID: 19231987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prions and their biology].
    Gasset M; Westaway D
    Rev Neurol; 2000 Jul 16-31; 31(2):129-32. PubMed ID: 10951668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.
    Igel A; Fornara B; Rezaei H; Béringue V
    Cell Tissue Res; 2023 Apr; 392(1):149-166. PubMed ID: 36399162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious prions and proteinopathies.
    Barron RM
    Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.
    Poggiolini I; Saverioni D; Parchi P
    Int J Cell Biol; 2013; 2013():910314. PubMed ID: 24454379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein and the molecular features of transmissible spongiform encephalopathy agents.
    Silveira JR; Caughey B; Baron GS
    Curr Top Microbiol Immunol; 2004; 284():1-50. PubMed ID: 15148986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.